Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Dec;6(12):689-97.
doi: 10.1038/nrendo.2010.187. Epub 2010 Oct 19.

The metabolic actions of glucagon revisited

Kirk M Habegger  1 , Kristy M Heppner, Nori Geary, Timothy J Bartness, Richard DiMarchi, Matthias H Tschöp
Affiliations
Review

The metabolic actions of glucagon revisited

Kirk M Habegger et al. Nat Rev Endocrinol. 2010 Dec.

Abstract

The initial identification of glucagon as a counter-regulatory hormone to insulin revealed this hormone to be of largely singular physiological and pharmacological purpose. Glucagon agonism, however, has also been shown to exert effects on lipid metabolism, energy balance, body adipose tissue mass and food intake. The ability of glucagon to stimulate energy expenditure, along with its hypolipidemic and satiating effects, in particular, make this hormone an attractive pharmaceutical agent for the treatment of dyslipidemia and obesity. Studies that describe novel preclinical applications of glucagon, alone and in concert with glucagon-like peptide 1 agonism, have revealed potential benefits of glucagon agonism in the treatment of the metabolic syndrome. Collectively, these observations challenge us to thoroughly investigate the physiology and therapeutic potential of insulin's long-known opponent.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Physiological stimuli and outcomes of glucagon secretion.
Figure 2
Figure 2
Individual and synergystic effects of glucagon-like peptide 1 and glucagon in obesity and pharmacotherapy.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Banting FG, Best CH. The internal secretion of the pancreas. J. Lab. Clin. Med. 1922;7:251–266. - PubMed
    1. Murlin JR, Clough HD, Gibbs CBF, Stokes AM. Aqueous extracts of the pancreas. I. Influence on the carbohydrate metabolism of depancreatized animals. J. Biol. Chem. 1923;56:253–296.
    1. Exton JH, Park CR. The role of cyclic AMP in the control of liver metabolism. Adv. Enzyme Regul. 1968;6:391–407. - PubMed
    1. Robison GA, Butcher RW, Sutherland EW. Cyclic AMP. Annu. Rev. Biochem. 1968;37:149–174. - PubMed
    1. Gu W, et al. Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia. J. Pharmacol. Exp. Ther. 2009;331:871–881. - PubMed